Market Currents
Transcept Pharmaceuticals (TSPT) has resumed trading, and is now up 17.6% in the wake of the...
-
Wednesday, November 23, 2011, 3:41 PM ETTranscept Pharmaceuticals (TSPT) has resumed trading, and is now up 17.6% in the wake of the FDA's approval of its Intermezzo insomnia drug.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
